8 insiders reported 11 Form 4 transactions for First Tracks Biotherapeutics, Inc. (TRAX) over the past 18 months (most recent 2026-09-17). Recent activity: Orwin John A (Director) Buy 1,300 shares, Ware J. Anthony (Director) Buy 39,265 shares, Ware J. Anthony (Director) Sell 39,265 shares, Jain Rita (Director) Buy 7,330 shares, Ware J. Anthony (Director) Buy 6,030 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-17 | Orwin John A | Director | Buy | 1,300 | $0 |
| 2026-09-04 | Ware J. Anthony | Director | Buy | 39,265 | $225,381 |
| 2026-09-04 | Ware J. Anthony | Director | Sell | 39,265 | $1.8M |
| 2026-06-17 | Jain Rita | Director | Buy | 7,330 | $0 |
| 2026-06-17 | Ware J. Anthony | Director | Buy | 6,030 | $0 |
| 2026-06-17 | FENTON DENNIS M | Director | Buy | 6,030 | $0 |
| 2026-06-17 | Orwin John A | Director | Buy | 6,030 | $0 |
| 2026-06-17 | Marquet Magda | Director | Buy | 6,030 | $0 |
| 2026-06-17 | Schmid John P. | Director | Buy | 6,030 | $0 |
| 2026-04-22 | ANAPTYSBIO, INC | 10% Owner | Sell | 100 | $0 |
| 2026-04-22 | EcoR1 Capital, LLC | 10% Owner | Buy | 4.7M | $65.0M |
来源：SEC Form 4 申报文件 · 截至 2026-09-17